For many couples undergoing in vitro fertilization (IVF), achieving a successful pregnancy involves more than creating healthy embryos. One important factor is ensuring that an embryo has the correct number of chromosomes, as chromosomal abnormalities are a common cause of implantation failure, miscarriage, and certain genetic conditions.
This is where Preimplantation Genetic Testing for Aneuploidy (PGT-A) can play an important role. PGT-A is an advanced laboratory technique used during IVF to evaluate embryos for chromosomal abnormalities before they are transferred to the uterus.
While PGT-A does not guarantee pregnancy or the birth of a healthy baby, it can provide valuable information that helps fertility specialists make more informed decisions about embryo selection.
In this guide, you’ll learn how PGT-A works, who may benefit from it, its advantages and limitations, and what current evidence says about its role in IVF.
What Is PGT-A?
PGT-A stands for Preimplantation Genetic Testing for Aneuploidy.
The test examines embryos created during IVF to determine whether they have the normal number of chromosomes.
A healthy embryo normally contains 46 chromosomes arranged in 23 pairs. An embryo with missing or extra chromosomes is called aneuploid.
Embryos with chromosomal abnormalities are generally less likely to implant successfully and may have a higher risk of miscarriage or certain genetic conditions.
PGT-A helps identify embryos that appear chromosomally normal (euploid), allowing the fertility team to make more informed embryo transfer decisions.
How Does PGT-A Work?
PGT-A is performed as part of an IVF cycle.
The typical process includes:
Step 1: Ovarian Stimulation
The ovaries are stimulated with fertility medications to produce multiple mature eggs.
Step 2: Egg Retrieval
The eggs are collected during a short outpatient procedure.
Step 3: Fertilization
The eggs are fertilized with sperm in the laboratory using conventional IVF or ICSI.
Step 4: Embryo Development
The embryos grow in the laboratory for approximately five to six days until they reach the blastocyst stage.
Step 5: Embryo Biopsy
A small number of cells are carefully removed from the outer layer of the embryo (trophectoderm). These cells later develop into the placenta, not the baby itself.
The biopsy is performed by experienced embryologists using specialized laboratory equipment.
Step 6: Genetic Analysis
The biopsied cells are analyzed using advanced genetic technologies to determine chromosome number.
Step 7: Embryo Transfer
Based on the results and the patient’s overall clinical picture, the fertility specialist selects an appropriate embryo for transfer in a subsequent cycle.
Why Are Chromosomes So Important?
Every embryo receives chromosomes from both the egg and the sperm.
As maternal age increases, the likelihood of chromosomal abnormalities also increases.
Chromosomal abnormalities may result in:
- Failed implantation
- Early miscarriage
- Certain genetic disorders
- Unsuccessful IVF cycles
By identifying embryos with a normal chromosome count, PGT-A can support embryo selection, although it cannot guarantee a successful pregnancy.
Who Should Consider PGT-A?
PGT-A may be considered for certain patients after discussion with a fertility specialist.
Examples include:
Women of Advanced Maternal Age
As egg quality changes with age, chromosomal abnormalities become more common, particularly after age 35.
Recurrent Pregnancy Loss
Some miscarriages are caused by chromosomal abnormalities. PGT-A may help identify embryos without detectable chromosome number abnormalities.
Repeated IVF Failure
Patients with multiple unsuccessful embryo transfers may discuss whether PGT-A is appropriate as part of a broader fertility evaluation.
Severe Male Factor Infertility
In selected cases, additional embryo assessment may be considered depending on the overall clinical situation.
Patients Seeking Single Embryo Transfer
PGT-A may help inform embryo selection when planning a single embryo transfer, although the decision depends on many factors.
What Are the Benefits of PGT-A?
Potential advantages include:
Improved Embryo Selection
PGT-A provides additional information about chromosome number that may assist in selecting an embryo for transfer.
Lower Risk of Transferring an Aneuploid Embryo
Testing may reduce the chance of transferring embryos with detectable chromosome number abnormalities.
Better Treatment Planning
The results can help fertility specialists discuss available options and tailor treatment plans.
Support for Single Embryo Transfer
When appropriate, identifying a euploid embryo may support the decision to transfer one embryo instead of multiple embryos.
What Are the Limitations?
Although PGT-A is a valuable laboratory tool, it has important limitations.
It Does Not Guarantee Pregnancy
A chromosomally normal embryo still needs to implant successfully, and many additional factors influence pregnancy outcomes.
Not Every Embryo Can Be Tested
Some embryos may stop developing before reaching the biopsy stage.
Mosaic Embryos
Occasionally, testing identifies embryos with both normal and abnormal cells (mosaic embryos). Management decisions should be made with experienced fertility specialists.
Cost
PGT-A increases the overall cost of an IVF cycle because it requires embryo biopsy and specialized laboratory analysis.
Is PGT-A Safe?
Current evidence suggests that embryo biopsy performed by experienced embryologists is generally considered safe within established IVF practice.
However, like every medical procedure, no intervention is entirely without limitations or potential risks.
Choosing an experienced fertility center with a high-quality embryology laboratory is essential.
Does PGT-A Improve IVF Success Rates?
This is one of the most frequently asked questions.
Current research indicates that PGT-A may improve embryo selection in certain patient groups, particularly where chromosomal abnormalities are more likely.
However, it does not improve egg quality or create healthier embryos, and it does not guarantee implantation or a live birth.
Whether PGT-A is appropriate depends on each patient’s age, medical history, ovarian reserve, previous IVF outcomes, and reproductive goals.
Preparing for PGT-A
If you are considering PGT-A, your fertility specialist may recommend:
- Comprehensive fertility evaluation
- Hormone testing
- Ultrasound assessment
- Semen analysis
- Genetic counseling when appropriate
- Discussion of expected benefits and limitations
A personalized treatment plan is always more valuable than a one-size-fits-all approach.
Pyetjet e bëra më shpesh
Does PGT-A detect all genetic diseases?
No. PGT-A primarily evaluates chromosome number. Other forms of preimplantation genetic testing are used for specific inherited genetic disorders.
Can a normal PGT-A result guarantee a healthy baby?
No. While a normal result provides useful information about chromosome number, no genetic test can guarantee a healthy pregnancy or baby.
Is PGT-A recommended for everyone undergoing IVF?
Not necessarily. The decision depends on individual medical history, age, fertility diagnosis, and discussion with a fertility specialist.
Will PGT-A increase my chances of pregnancy?
For selected patients, PGT-A may support embryo selection and treatment planning. Whether it improves outcomes varies depending on the individual clinical situation.
Can younger women benefit from PGT-A?
Some younger patients may choose PGT-A based on their medical history or previous reproductive outcomes, but it is not routinely necessary for every IVF cycle.
Final Thoughts
Preimplantation Genetic Testing for Aneuploidy (PGT-A) has become an important tool in modern IVF, providing additional information about the chromosomal makeup of embryos before transfer.
While it is not a guarantee of pregnancy, PGT-A may help fertility specialists make more informed embryo selection decisions for certain patients, particularly those with advanced maternal age, recurrent pregnancy loss, or previous IVF challenges.
The decision to include PGT-A in an IVF treatment plan should always be made after a thorough consultation with an experienced fertility specialist. Every fertility journey is unique, and personalized care remains the foundation of successful treatment.
